Burden of atopic dermatitis in paediatric patients: an international cross-sectional study
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljad449 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Stephan Weidinger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Allergology and Venereology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Quality of Life, Cost of Illness. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi, Regeneron.
Abstract (Originalsprache)
Background
Few large-scale international studies have broadly characterized the burden of atopic dermatitis (AD) across age groups among children and adolescents.
Objectives
To better characterize the AD burden in paediatric patients by disease severity.
Methods
This cross-sectional, web-based survey of paediatric patients (6 months to < 18 years old) was conducted in 18 countries representing North America, Latin America, Europe, Middle East/Eurasia and East Asia. Patients with diagnosed AD were identified based on the International Study of Asthma and Allergies in Childhood criteria and self-/parent-report of ever being told by a physician that they or their child had eczema. AD severity was assessed using the Patient-Oriented Eczema Measure and Patient Global Assessment. Outcomes included measures of itch, skin pain, sleep, health-related quality of life (HRQoL), missed school days and atopic comorbidities.
Results
The survey included 1489 children aged 6 months to < 6 years; 2898 children aged 6 to < 12 years; and 3078 adolescents aged 12 to < 18 years diagnosed with AD. Although the burden of mild AD was substantial, paediatric patients with moderate or severe AD had more itch, skin pain, sleep problems and impaired HRQoL, and missed more school days relative to those with mild AD; greater burden was observed among those with severe relative to moderate AD. At least one atopic comorbidity was present in 92.5% of all respondents.
Conclusions
These results highlight the burden of AD in paediatric patients, especially those with moderate-to-severe disease, and suggest the need for assessments that include the impact of AD on function and daily life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Allergology and Venereology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Oregon Health and Science University, Portland, OR, USA.
- Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
- Centre Hospitalier Universitaire de Nantes, Nantes, France.
- Sanofi, Chilly-Mazarin, France.
- Regeneron, Tarrytown, NY, USA.
ORCID-Profile: Jonathan I Silverberg, Sebastien Barbarot
Förderung
- Sanofi
- Regeneron
Zitieren
APA
Weidinger, S., Simpson, E. L., Silverberg, J. I., Barbarot, S., Eckert, L., Mina-Osorio, P., Rossi, A. B., Brignoli, L., Mnif, T., Guillemin, I., Fenton, M. C., Delevry, D., Chuang, C. C., Pellan, M., & Gadkari, A. (2024). Burden of atopic dermatitis in paediatric patients: an international cross-sectional study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad449
Vancouver
Weidinger S, Simpson EL, Silverberg JI, Barbarot S, Eckert L, Mina-Osorio P, et al. Burden of atopic dermatitis in paediatric patients: an international cross-sectional study. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljad449
BibTeX
@article{Weidinger2024,
author = {Weidinger, Stephan and Simpson, Eric L and Silverberg, Jonathan I and Barbarot, Sebastien and Eckert, Laurent and Mina-Osorio, Paola and Rossi, Ana B and Brignoli, Lysel and Mnif, Tarek and Guillemin, Isabelle and Fenton, Miriam C and Delevry, Dimittri and Chuang, Chien-Chia and Pellan, Marine and Gadkari, Abhijit},
title = {Burden of atopic dermatitis in paediatric patients: an international cross-sectional study},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljad449}
}
EUVIMED